Effects of Symbicort [budesonide/formoterol] single inhaler therapy on bronchial hyper responsiveness, asthma control and safety in mild to moderate asthmatics in general practice, compared to usual care therapy

Trial Profile

Effects of Symbicort [budesonide/formoterol] single inhaler therapy on bronchial hyper responsiveness, asthma control and safety in mild to moderate asthmatics in general practice, compared to usual care therapy

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jan 2011

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top